Im Cannabis Corp Stock Performance
| IMCC Stock | USD 2.81 0.04 1.44% |
The company owns a Beta (Systematic Risk) of 0.0483, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Im Cannabis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Im Cannabis is expected to be smaller as well. Im Cannabis Corp at this time owns a risk of 4.8%. Please check out Im Cannabis Corp treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to decide if Im Cannabis Corp will be following its current price history.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Im Cannabis Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Im Cannabis is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 2.4 M | |
| Free Cash Flow | -8.7 M |
IMCC |
Im Cannabis Relative Risk vs. Return Landscape
If you would invest 293.00 in Im Cannabis Corp on August 24, 2024 and sell it today you would lose (12.00) from holding Im Cannabis Corp or give up 4.1% of portfolio value over 90 days. Im Cannabis Corp is currently generating 0.0462% in daily expected returns and assumes 4.8038% risk (volatility on return distribution) over the 90 days horizon. In different words, 42% of stocks are less volatile than IMCC, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Im Cannabis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Im Cannabis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Im Cannabis Corp, and traders can use it to determine the average amount a Im Cannabis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0096
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMCC |
Estimated Market Risk
| 4.8 actual daily | 42 58% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Im Cannabis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Im Cannabis by adding Im Cannabis to a well-diversified portfolio.
Im Cannabis Fundamentals Growth
IMCC Stock prices reflect investors' perceptions of the future prospects and financial health of Im Cannabis, and Im Cannabis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IMCC Stock performance.
| Return On Equity | -1.12 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.28) % | ||||
| Operating Margin | (0.20) % | ||||
| Current Valuation | 18.08 M | ||||
| Shares Outstanding | 3.09 M | ||||
| Price To Book | 2.00 X | ||||
| Price To Sales | 0.17 X | ||||
| Revenue | 48.8 M | ||||
| EBITDA | (2.79 M) | ||||
| Cash And Equivalents | 5.86 M | ||||
| Cash Per Share | 0.08 X | ||||
| Total Debt | 13.78 M | ||||
| Debt To Equity | 0.20 % | ||||
| Book Value Per Share | 6.48 X | ||||
| Cash Flow From Operations | (8.07 M) | ||||
| Earnings Per Share | (4.12) X | ||||
| Total Asset | 48.81 M | ||||
| Retained Earnings | (249.15 M) | ||||
About Im Cannabis Performance
By analyzing Im Cannabis' fundamental ratios, stakeholders can gain valuable insights into Im Cannabis' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Im Cannabis has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Im Cannabis has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. The company serves medical patients and adult-use recreational consumers. IM Cannabis is traded on NASDAQ Exchange in the United States.Things to note about Im Cannabis Corp performance evaluation
Checking the ongoing alerts about Im Cannabis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Im Cannabis Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Im Cannabis Corp had very high historical volatility over the last 90 days | |
| Im Cannabis Corp has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 48.8 M. Net Loss for the year was (10.23 M) with profit before overhead, payroll, taxes, and interest of 9.16 M. | |
| Im Cannabis Corp currently holds about 5.86 M in cash with (8.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. | |
| Roughly 47.0% of the company shares are held by company insiders |
- Analyzing Im Cannabis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Im Cannabis' stock is overvalued or undervalued compared to its peers.
- Examining Im Cannabis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Im Cannabis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Im Cannabis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Im Cannabis' stock. These opinions can provide insight into Im Cannabis' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for IMCC Stock analysis
When running Im Cannabis' price analysis, check to measure Im Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Im Cannabis is operating at the current time. Most of Im Cannabis' value examination focuses on studying past and present price action to predict the probability of Im Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Im Cannabis' price. Additionally, you may evaluate how the addition of Im Cannabis to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |